- Used at the point-of-care to quickly detect and differentiate COVID-19, Influenza A, and Influenza B from a single patient sample
Uses
- Diagnosis:
- Detects nucleocapsid protein antigens for SARS-CoV-2, Influenza A, and Influenza B in direct nasal or nasopharyngeal swabs
- Symptomatic Patients:
- Intended for individuals suspected of respiratory viral infections within the first 5 days of symptom onset
- Asymptomatic Screening:
- Can be used serially (multiple times over a few days) for asymptomatic testing
Features
- Three Results, One Sample:
- Tests for Flu A, Flu B, and COVID-19 at the same time, conserving patient comfort and clinical materials
- Fast Turnaround:
- Delivers automated and objective results in just 15 minutes
- Instrument-Read:
- Utilizes advanced fluorescent immunoassay (FIA) technology with the Sofia 2 Analyzer to eliminate subjective visual interpretation
- CLIA Waived:
- Classified as CLIA-waived when used with nasal and nasopharyngeal swabs, making it easy to perform in diverse point-of-care settings
Benefits
- Rapid Treatment Decisions:
- Providing results in 15 minutes allows healthcare providers to quickly isolate patients, prescribe antivirals (like for the flu), and manage treatment protocols efficiently
- High Accuracy:
- Provides high sensitivity and specificity. The fluorescent technology removes human error, yielding consistent and reliable results
- Flexible Workflow:
- Compatible with "Walk Away" and "Read Now" modes on the Sofia 2 analyzer, allowing staff to multitask or get immediate results
- Complete Kit:
- The Sofia 2 Flu + SARS Antigen FIA Kit contains all required components (cassettes, swabs, reagents, and positive/negative controls) for 25 distinct tests
